Effect of ladasten on proliferative activity and apoptosis in peripheral blood T-lymphocytes ]
Vakhitova IuV, Sibiriak SV, Kurchatova NN, Seredenin SB · 2002 · Eksperimental'naia i klinicheskaia farmakologiia 65(6):49-52. PMID 12596534
What does this source report?
Studies proliferation and resistance to chemically induced apoptosis in cultured T cells.
- Population and setting
- Activated human peripheral-blood T lymphocytes in culture
- Evidence type
- In vitro
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Human-derived cells are not a clinical trial; culture concentrations do not establish therapeutic exposure or immune benefit.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Vakhitova IuV, Sibiriak SV, Kurchatova NN, Seredenin SB. Effect of ladasten on proliferative activity and apoptosis in peripheral blood T-lymphocytes ] Eksperimental'naia i klinicheskaia farmakologiia 65(6):49-52. PMID 12596534 2002.
Molekul research summary: https://molekul.io/research/acto-12596534. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry